NCT00034177View on ClinicalTrials.gov

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Urologic Neoplasms
Interventions
DRUG

S-8184 Paclitaxel Injectable Emulsion

DRUG

Experimental Arm: TOCOSOL Paclitaxel

Doses of 80, 100 and 120mg/m2

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY